Synergistic costimulatory effect of chlamydia pneumoniae with carbon nanoparticles on NLRP3 inflammasome-mediated interleukin-1β secretion in macrophages

Infection and Immunity

Volumn 83, Issue 7, 2015, Pages 2917-2925

  Matsuo, Junji ^a   Nakamura, Shinji ^b   Takeda, Seiji ^a   Ishida, Kasumi ^a,c   Yamazaki, Tomohiro ^a,c   Yoshida, Mitsutaka ^b   Chiba, Hitoshi ^a   Hui, Shu Ping ^a   Yamaguchi, Hiroyuki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON NANOPARTICLE; CARBON NANOTUBE; CATHEPSIN B INHIBITOR; CRYOPYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 8; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; CARBON; CARRIER PROTEIN; NANOPARTICLE; NLRP3 PROTEIN, HUMAN;

ACTIN POLYMERIZATION; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MACROPHAGE; MOLECULAR MECHANICS; PATHOGENESIS; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; CELL LINE; CHLAMYDIA PNEUMONIAE; ENDOCYTOSIS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; SECRETION (PROCESS);

CARBON; CARRIER PROTEINS; CASPASE 1; CELL LINE; CHLAMYDOPHILA PNEUMONIAE; ENDOCYTOSIS; GENE SILENCING; HUMANS; INFLAMMASOMES; INTERLEUKIN-1BETA; MACROPHAGES; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN;

EID: 84930995025     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02968-14     Document Type: Article

References (41)

1. Grayston JT. 1992. Chlamydia pneumoniae, strain TWAR pneumonia. Annu Rev Med 43:317-323. http://dx.doi.org/10.1146/annurev.me.43 .020192.001533.
2. Kuo CC, Jackson LA, Campbell LA, Grayston JT. 1995. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 8:451-461.
3. Blasi F, Tarsia P, Aliberti S. 2009. Chlamydophila pneumoniae. Clin Microbiol Infect 15:29-35. http://dx.doi.org/10.1111/j.1469-0691.2008 .02130.x.
4. Roulis E, Polkinghorne A, Timms P. 2013. Chlamydia pneumoniae: modern insights into an ancient pathogen. Trends Microbiol 21:120-128. http://dx.doi.org/10.1016/j.tim.2012.10.009.
5. He X, Mekasha S, Mavrogiorgos N, Fitzgerald KA, Lien E, Ingalls RR. 2010. Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome. J Immunol 184: 5743-5754. http://dx.doi.org/10.4049/jimmunol.0903937.
6. Netea MG, Selzman CH, Kullberg BJ, Galama JM, Weinberg A, Stalenhoef AF, Van der Meer JW, Dinarello CA. 2000. Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. Eur J Immunol 30:541-549. http://dx.doi.org/10.1002/1521-4141(200002)30:2<541::AID-IMMU541>3.0.CO;2-X.
7. Heinemann M, Susa M, Simnacher U, Marre R, Essig A. 1996. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect Immun 64:4872-4875.
8. Kaukoranta-Tolvanen SS, Teppo AM, Laitinen K, Saikku P, Linnavuori K, Leinonen M. 1996. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog 21:215-221. http://dx.doi.org/10.1006/mpat .1996.0056.
9. Delzell JE, Jr. 2013. Common lung conditions: environmental pollutants and lung disease. FP Essent 409:32-42.
10. Ganguly K, Upadhyay S, Irmler M, Takenaka S, Pukelsheim K, Beckers J, De Angelis MH, Hamelmann E, Stoeger T, Schulz H. 2011. Impaired resolution of inflammatory response in the lungs of JF1/Msf mice following carbon nanoparticle instillation. Respir Res 12:94. http://dx.doi.org /10.1186/1465-9921-12-94.
11. Murr LE, Garza KM, Soto KF, Carrasco A, Powell TG, Ramirez DA, Guerrero PA, Lopez DA, Venzor J, III. 2005. Cytotoxicity assessment of some carbon nanotubes and related carbon nanoparticle aggregates and the implications for anthropogenic carbon nanotube aggregates in the environment. Int J Environ Res Public Health 2:31-42. http://dx.doi.org /10.3390/ijerph2005010031.
12. Palomäki J, Välimäki E, Sund J, Vippola M, Clausen PA, Jensen KA, Savolainen K, Matikainen S, Alenius H. 2011. Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism. ACS Nano 5:6861-6870. http://dx.doi.org/10.1021 /nn200595c.
13. Reisetter AC, Stebounova LV, Baltrusaitis J, Powers L, Gupta A, Grassian VH, Monick MM. 2011. Induction of inflammasome-dependent pyroptosis by carbon black nanoparticles. J Biol Chem 286:21844-21852. http://dx.doi.org/10.1074/jbc.M111.238519.
14. Meunier E, Coste A, Olagnier D, Authier H, Lefèvre L, Dardenne C, Bernad J, Béraud M, Flahaut E, Pipy B. 2012. Double-walled carbon nanotubes trigger IL-1beta release in human monocytes through Nlrp3inflammasome activation. Nanomedicine 8:987-995. http://dx.doi.org/10 .1016/j.nano.2011.11.004.
15. Horvath GL, Schrum JE, De Nardo CM, Latz E. 2011. Intracellular sensing of microbes and danger signals by the inflammasomes. Immunol Rev 243:119-135. http://dx.doi.org/10.1111/j.1600-065X.2011.01050.x.
16. Gross O, Thomas CJ, Guarda G, Tschopp J. 2011. The inflammasome: an integrated view. Immunol Rev 243:136-151. http://dx.doi.org/10.1111 /j.1600-065X.2011.01046.x.
17. Martinon F, Tschopp J. 2004. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117: 561-574. http://dx.doi.org/10.1016/j.cell.2004.05.004.
18. Saïd-Sadier N, Ojcius DM. 2012. Alarmins, inflammasomes and immunity. Biomed J 35:437-439. http://dx.doi.org/10.4103/2319-4170.104408.
19. Eitel J, Meixenberger K, van Laak C, Orlovski C, Hocke A, Schmeck B, Hippenstiel S, N'Guessan PD, Suttorp N, Opitz B. 2012. Rac1 regulates the NLRP3 inflammasome which mediates IL-1beta production in Chlamydophila pneumoniae infected human mononuclear cells. PLoS One 7:e30379. http://dx.doi.org/10.1371/journal.pone.0030379.
20. Shimada K, Crother TR, Arditi M. 2012. Innate immune responses to Chlamydia pneumoniae infection: role of TLRs, NLRs, and the inflammasome. Microbes Infect 14:1301-1307. http://dx.doi.org/10.1016/j .micinf.2012.08.004.
21. Ishida K, Kubo T, Saeki A, Yamane C, Matsuo J, Yimin Nakamura S, Hayashi Y, Kunichika M, Yoshida M, Takahashi K, Hirai I, Yamamoto Y, Shibata K, Yamaguchi H. 2013. Chlamydophila pneumoniae in human immortal Jurkat cells and primary lymphocytes uncontrolled by interferon-gamma. Microbes Infect 15:192-200. http://dx.doi.org/10.1016/j .micinf.2012.11.006.
22. Takeda S, Hui SP, Fuda H, Jin S, Sakurai T, Ishii A, Mukasa K, Sueoka K, Chiba H. 2013. Evaluation of various electrode materials for detection of oxidized low-density lipoproteins. J Biomed Nanotechnol 9:303-306. http://dx.doi.org/10.1166/jbn.2013.1518.
23. Miura K, Matsuo J, Rahman MA, Kumagai Y, Li X, Rikihisa Y. 2011. Ehrlichia chaffeensis induces monocyte inflammatory responses through MyD88, ERK, and NF-kappaB but not through TRIF, interleukin-1 receptor 1 (IL-1R1)/IL-18R1, or Toll-like receptors. Infect Immun 79:4947-4956. http://dx.doi.org/10.1128/IAI.05640-11.
24. Gnoatto N, Lotufo RF, Matsuda M, Penna V, Marquezini MV. 2007. Expression of cell-surface heparan sulfate proteoglycans in human cyclosporin-induced gingival overgrowth. J Periodont Res 42:553-558. http: //dx.doi.org/10.1111/j.1600-0765.2007.00981.x.
25. Madico G, Quinn TC, Boman J, Gaydos CA. 2000. Touchdown enzyme time release-PCR for detection and identification of Chlamydia trachomatis, C. pneumoniae, and C. psittaci using the 16S and 16S-23S spacer rRNA genes J Clin Microbiol 38:1085-1093.
26. Petrilli V, Papin S, Dostert C, Mayor A, Martinon F, Tschopp J. 2007. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 14:1583-1589. http://dx.doi .org/10.1038/sj.cdd.4402195.
27. Meixenberger K, Pache F, Eitel J, Schmeck B, Hippenstiel S, Slevogt H, N'Guessan P, Witzenrath M, Netea MG, Chakraborty T, Suttorp N, Opitz B. 2010. Listeria monocytogenes-infected human peripheral blood mononuclear cells produce IL-1beta, depending on listeriolysin O and NLRP3. J Immunol 184:922-930. http://dx.doi.org/10.4049/jimmunol .0901346.
28. Hornung V, Latz E. 2010. Critical functions of priming and lysosomal damage for NLRP3 activation. Eur J Immunol 40:620-623. http://dx.doi .org/10.1002/eji.200940185.
29. Tschopp J, Schroder K. 2010. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10:210-215. http://dx.doi.org/10.1038/nri2725.
30. Brown JS. 2012. Community-acquired pneumonia. Clin Med 12:538-543. http://dx.doi.org/10.7861/clinmedicine.12-6-538.
31. Sabet SF, Simmons J, Caldwell HD. 1984. Enhancement of Chlamydia trachomatis infectious progeny by cultivation of HeLa 229 cells treated with DEAE-dextran and cycloheximide. J Clin Microbiol 20:217-222.
32. Prebeck S, Kirschning C, Dürr S, da Costa C, Donath B, Brand K, Redecke V, Wagner H, Miethke T. 2001. Predominant role of Toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells. J Immunol 167:3316-3323. http://dx.doi.org/10.4049 /jimmunol.167.6.3316.
33. Jiang SJ, Kuo CC, Berry MW, Lee AW, Campbell LA. 2008. Identification and characterization of Chlamydia pneumoniae-specific proteins that activate tumor necrosis factor alpha production in RAW 264.7 murine macrophages. Infect Immun 76:1558-1564. http://dx.doi.org/10.1128 /IAI.01331-07.
34. Abdul-Sater AA, Said-Sadier N, Padilla EV, Ojcius DM. 2010. Chlamydial infection of monocytes stimulates IL-1beta secretion through activation of the NLRP3 inflammasome. Microbes Infect 12:652-661. http://dx .doi.org/10.1016/j.micinf.2010.04.008.
35. Abdul-Sater AA, Koo E, Hacker G, Ojcius DM. 2009. Inflammasomedependent caspase-1 activation in cervical epithelial cells stimulates growth of the intracellular pathogen Chlamydia trachomatis. J Biol Chem 284:26789-26796. http://dx.doi.org/10.1074/jbc.M109.026823.
36. Ying S, Pettengill M, Ojcius DM, Häcker G. 2007. Host-cell survival and death during Chlamydia infection. Curr Immunol Rev 3:31-40. http://dx .doi.org/10.2174/157339507779802179.
37. Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S, Ramanujan VK, Wolf AJ, Vergnes L, Ojcius DM, Rentsendorj A, Vargas M, Guerrero C, Wang Y, Fitzgerald KA, Underhill DM, Town T, Arditi M. 2012. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36:401-414. http://dx.doi.org/10 .1016/j.immuni.2012.01.009.
38. Duprez L, Wirawan E, Vanden Berghe T, Vandenabeele P. 2009. Major cell death pathways at a glance. Microbes Infect 11:1050-1062. http://dx .doi.org/10.1016/j.micinf.2009.08.013.
39. Silveira TN, Zamboni DS. 2010. Pore formation triggered by Legionella spp. is an Nlrc4 inflammasome-dependent host cell response that precedes pyroptosis. Infect Immun 78:1403-1413. http://dx.doi.org/10.1128 /IAI.00905-09.
40. Lage SL, Amarante-Mendes GP, Bortoluci KR. 2013. Evaluation of pyroptosis in macrophages using cytosolic delivery of purified flagellin. Methods 61:110-116. http://dx.doi.org/10.1016/j.ymeth.2013.02.010.
41. Broz P, von Moltke J, Jones JW, Vance RE, Monack DM. 2010. Differential requirement for caspase-1 autoproteolysis in pathogeninduced cell death and cytokine processing. Cell Host Microbe 8:471-483. http://dx.doi.org/10.1016/j.chom.2010.11.007.